Lectures and seminars Hormone-driven cancers in time and space from trials to mechanisms and back again 

04-06-2026 3:30 pm Add to iCal
Hybrid Venue: Air&Fire, SciLifeLab, Tomtebodavägen 23, Solna  Online: Connect to the event

Welcome to a seminar with Professor Wilbert Zwart, arranged by the Gastroenterology and Nutrition Unit (GUT) at the Department of Medicine, Huddinge.

Speaker

Professor Wilbert Zwart, the Netherlands Cancer Institute (NKI; Amsterdam) and Eindhoven University of Technology. 

Title

Hormone-driven cancers in time and space from trials to mechanisms and back again 

Host

Docent Cecilia Williams, GUT, MedH, KI.

About the speaker

Wilbert Zwart completed his PhD at the Netherlands Cancer Institute (NKI; Amsterdam) in 2009, and received his post-doctoral training at the CRUK-CI in Cambridge (UK), in the lab of Prof. Jason Carroll. 

In 2011, Wilbert returned to the Netherlands to open his independent research lab at the NKI studying hormone-dependent cancers, focusing on hormone receptor biology, epigenetics, and gene regulation. His projects have a ‘full circle’ design, connecting basic scientific discoveries, translational research, and clinical trials. By implementing functional genomics and molecular endocrinology in innovative clinical trials, basic scientific breakthroughs can be best connected with the patient, allowing for a swift translation of these discoveries to the clinic. 

In 2018, he was appointed senior group leader at the NKI, as well as full professor at the Eindhoven University of Technology, and a member of the Oncode Institute. He serves as Chair of the NKI Translational Research Board, theme lead Precision Oncology of the NKI, and takes a seat on the Board of Directors of Cancer Core Europe.

Recent Publication: Padrão N, Severson TM, Gregoricchio S, Guijarro A, Lutz C, Taranto D, Hutten S, Ligorio F, Persia A, Roest M, Sanders J, Song JY, Pires-Oliveira S, Donaldson Collier M, Horlings H, Pisciotta L, de Braud F, Vernieri C, Akkari L, Jonkers J, Nencioni A, Caffa I, Zwart W. Fasting boosts breast cancer therapy efficacy via glucocorticoid activation. Nature. 2026 Jan